BeiGene
BeiGene is a biotechnology company that develops and commercializes immunotherapeutics for the treatment of cancer.
Business Model:
Revenue: $1.2B
Employees: 5,001-10,000
Industries / Tags:
Detailed BeiGene Information
Geographic Data
Address: 30 Science Park Road
City: Beijing
State: beijing municipality
Zip: 102206
Country: CN
Financial Info
Stage:
post ipo equity
Raised Last:
$2B
Raised Total:$3B
Social
Metrics
373,501Website Global Rank
146,589Website Monthly Traffic
Twitter Followers
Description
BeiGene is a biotechnology company that develops and commercializes immunotherapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
BeiGene went public on 12/15/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/15/2021
Ticker Symbol:
688235
IPO Price:
$30.246874803693697/share
Amount Raised:
$4B
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2021 | Strand Therapeutics | Series A | 52M |
| 3/2021 | Boston Immune Technologies &a; Therapeutics | Series A | 10M |
| 11/2021 | Shoreline Biosciences | Series B | 0 |
| 1/2020 | Leap Therapeutics | Post-IPO Equity | 0 |
| 11/2021 | Shoreline Biosciences | Series B | 0 |
| 6/2021 | Strand Therapeutics | Series A | 0 |
| 3/2021 | Boston Immune Technologies &a; Therapeutics | Series A | 0 |
| 1/2020 | Leap Therapeutics | Post-IPO Equity | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2014 | Series A | 2 | $75M |
Hillhouse Capital Group CITIC Capital Holdings CITIC Capital Holdings Hillhouse Capital Group Hillhouse Capital Group CITIC Capital Holdings CITIC Capital Holdings Hillhouse Capital Group |
11/2016 | Secondary Offering | $200M | 2/2016 | IPO | $158M | 8/2018 | Post-IPO Secondary | $903M | 5/2015 | Series B | 3 | $97M |
Rock Springs Capital Hillhouse Capital Group T. Rowe Price Hillhouse Capital Group Rock Springs Capital Hillhouse Capital Group T. Rowe Price Hillhouse Capital Group |
7/2020 | Post-IPO Equity | 3 | $2.1B |
Hillhouse Capital Group Amgen Ventures GIC Hillhouse Capital Group Hillhouse Capital Group Amgen Ventures GIC Hillhouse Capital Group |
11/2016 | Post-IPO Equity | $185M | 5/2015 | Private Equity Round | $96.6M |
Hillhouse Capital Group T. Rowe Price Rock Springs Capital Management CITIC PE |
1/2018 | Post-IPO Equity | $750M | 10/2019 | Post-IPO Equity | 1 | $2.7B |
Amgen Amgen Amgen Amgen |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
